Control of CAR-T cell activity in space and time: the next level of anti-tumor action

被引：0
|
作者：
Jessica Hoppstädter
Alexandra K. Kiemer
机构：
[1] Saarland University,Department of Pharmacy, Pharmaceutical Biology
来源：
Signal Transduction and Targeted Therapy | / 8卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Engineered triple inhibitory receptor resistance improves anti-tumor CAR-T cell performance via CD56
    Fan Zou
    Lijuan Lu
    Jun Liu
    Baijin Xia
    Wanying Zhang
    Qifei Hu
    Weiwei Liu
    Yiwen Zhang
    Yingtong Lin
    Shuliang Jing
    Mei Huang
    Bifen Huang
    Bingfeng Liu
    Hui Zhang
    Nature Communications, 10
  • [32] Anti-tumor efficacy of human anti-c-met CAR-T cells against papillary renal cell carcinoma in an orthotopic model
    Mori, Jun-ich
    Adachi, Keishi
    Sakoda, Yukimi
    Sasaki, Takahiro
    Goto, Shunsuke
    Matsumoto, Hiroaki
    Nagashima, Yoji
    Matsuyama, Hideyasu
    Tamada, Koji
    CANCER SCIENCE, 2021, 112 (04) : 1417 - 1428
  • [33] Engineered triple inhibitory receptor resistance improves anti-tumor CAR-T cell performance via CD56
    Zou, Fan
    Lu, Lijuan
    Liu, Jun
    Xia, Baijin
    Zhang, Wanying
    Hu, Qifei
    Liu, Weiwei
    Zhang, Yiwen
    Lin, Yingtong
    Jing, Shuliang
    Huang, Mei
    Huang, Bifen
    Liu, Bingfeng
    Zhang, Hui
    NATURE COMMUNICATIONS, 2019, 10 (1)
  • [34] Endosome-microautophagy targeting chimera (eMIATAC) for targeted proteins degradation and enhance CAR-T cell anti-tumor therapy
    Lei, Kunjian
    Li, Jingying
    Tu, Zewei
    Gong, Chuandong
    Liu, Junzhe
    Luo, Min
    Ai, Wenqian
    Wu, Lei
    Li, Yishuang
    Zhou, Zhihong
    Chen, Zhihao
    Lv, Shigang
    Ye, Minhua
    Wu, Miaojing
    Long, Xiaoyan
    Zhu, Xingen
    Huang, Kai
    THERANOSTICS, 2024, 14 (11): : 4481 - 4498
  • [35] Anti-tumor efficacy and safety of conditionally activated armored CAR-T cells against gastrointestinal tumors
    Huang, Z.
    Zhang, X.
    Han, D.
    Thiery, J. P.
    ANNALS OF ONCOLOGY, 2024, 35 : S695 - S695
  • [36] Small molecule inhibitor of ubiquitin ligase CBL-B enhanced anti-tumor response of CAR-T and CAR-NK cell therapies
    Yang, Cuiqing
    Wang, Yifang
    Liu, Tingting
    Jiang, Fuwei
    Wang, Chao
    Wang, Qingyang
    Wang, Qin
    Li, Zhengtao
    Mai, Wansun
    Ye, Gang
    Tang, Renhong
    Cao, Zhuoxiao
    CANCER RESEARCH, 2023, 83 (07)
  • [37] Next generation CAR-T cell therapy for solid tumors
    Tamada, Koji
    CANCER SCIENCE, 2021, 112 : 1022 - 1022
  • [38] Phosphatidylserine as a tumor target for CAR-T cell therapy
    Martin-Otal, Celia
    Sanchez-Moreno, Ines
    Gomez-Moron, Alvaro
    Castro, Carla
    Casares, Noelia
    Navarro, Flor
    Gorraiz, Marta
    Justicia-Lirio, Pedro
    Pareja, Felix
    Collantes, Maria
    Penuelas, Ivan
    Inarrairaegui, Mercedes
    Sangro, Bruno
    Vivas, Isabel
    Larrayoz, Marta
    Rodriguez, Juan Roberto
    Prosper, Felipe
    Hervas-Stubbs, Sandra
    Martin-Cofreces, Noa
    Lasarte, Juan Jose
    Lozano, Teresa
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2025, 13 (02)
  • [39] Inducible localized delivery of an anti-PD-1 scFv enhances anti-tumor activity of ROR1 CAR-T cells in TNBC
    Harrasser, Micaela
    Gohil, Satyen Harish
    Lau, Hiu
    Della Peruta, Marco
    Muczynski, Vincent
    Patel, Dominic
    Miranda, Elena
    Grigoriadis, Kristiana
    Grigoriadis, Anita
    Granger, David
    Evans, Rachel
    Nathwani, Amit Chunilal
    BREAST CANCER RESEARCH, 2022, 24 (01)
  • [40] Enhancing the Persistence and Anti-Tumor Efficacy of CAR-T and CAR-NK Cells through Genetic Disruption of Death Receptors
    Cohen, Tal Dror
    Yi, Fei
    Zumbo, Paul
    Etilib, Razan
    Arkin, Hannah
    Gormally, Michael, V
    Hackett, Christopher S.
    Kropp, Korbinian
    Etxeberria, Inaki
    Chandran, Smita S.
    Park, Jae H.
    Betel, Doron
    Klebanoff, Christopher
    TRANSPLANTATION AND CELLULAR THERAPY, 2025, 31 (02):
12345